Literature DB >> 8017326

Urinary lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder.

J W Lampe1, M C Martini, M S Kurzer, H Adlercreutz, J L Slavin.   

Abstract

Lignans and isoflavonoid phytoestrogens, produced from plant precursors by colonic bacteria, may protect against certain cancers. We examined the effects of flaxseed consumption on urinary lignans and isoflavonoids. Eighteen women consumed their usual omnivorous diets for three menstrual cycles and their usual diets supplemented with flaxseed powder (10 g/d) for three cycles in a randomized crossover design. Three-day urine samples from follicular and luteal phases were analyzed for lignans and isoflavonoids by isotope-dilution gas chromatography--mass spectrometry. Excretion of the lignans enterodiol and enterolactone increased with flaxseed from 1.09 +/- 1.08 and 3.16 +/- 1.47 to 19.48 +/- 1.10 and 27.79 +/- 1.50 mumol/d, respectively (P < 0.0002). Enterodiol and enterolactone excretion varied among subjects in response to flaxseed (3- to 285-fold increase). There were no differences in excretion of isoflavonoids (daidzein, genistein, equol, and O-desmethylangolensin) or the lignan matairesinol with flaxseed. Excretion was not altered by phase of menstrual cycle or duration of flaxseed consumption.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8017326     DOI: 10.1093/ajcn/60.1.122

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  12 in total

Review 1.  Interindividual differences in phytochemical metabolism and disposition.

Authors:  Johanna W Lampe; Jyh-Lurn Chang
Journal:  Semin Cancer Biol       Date:  2007-05-13       Impact factor: 15.707

Review 2.  Pharmacokinetic evaluation of herbal remedies. Basic introduction, applicability, current status and regulatory needs.

Authors:  P A De Smet; J R Brouwers
Journal:  Clin Pharmacokinet       Date:  1997-06       Impact factor: 6.447

3.  Colonic mucosal and exfoliome transcriptomic profiling and fecal microbiome response to a flaxseed lignan extract intervention in humans.

Authors:  Johanna W Lampe; Eunji Kim; Lisa Levy; Laurie A Davidson; Jennifer S Goldsby; Fayth L Miles; Sandi L Navarro; Timothy W Randolph; Ni Zhao; Ivan Ivanov; Andrew M Kaz; Christopher Damman; David M Hockenbery; Meredith A J Hullar; Robert S Chapkin
Journal:  Am J Clin Nutr       Date:  2019-08-01       Impact factor: 7.045

Review 4.  Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings.

Authors:  Susan Arentz; Jason Anthony Abbott; Caroline Anne Smith; Alan Bensoussan
Journal:  BMC Complement Altern Med       Date:  2014-12-18       Impact factor: 3.659

5.  Enterolignan-producing phenotypes are associated with increased gut microbial diversity and altered composition in premenopausal women in the United States.

Authors:  Meredith A J Hullar; Samuel M Lancaster; Fei Li; Elizabeth Tseng; Karlyn Beer; Charlotte Atkinson; Kristiina Wähälä; Wade K Copeland; Timothy W Randolph; Katherine M Newton; Johanna W Lampe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12-26       Impact factor: 4.254

6.  Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans.

Authors:  Kenneth D R Setchell; Nadine M Brown; Linda Zimmer-Nechemias; Brian Wolfe; Pinky Jha; James E Heubi
Journal:  Food Funct       Date:  2014-03       Impact factor: 5.396

7.  Plasma enterolactone and breast cancer risk in the Nurses' Health Study II.

Authors:  Jing Xie; Shelley S Tworoger; Adrian A Franke; Kathryn L Terry; Megan S Rice; Bernard A Rosner; Walter C Willett; Susan E Hankinson; A Heather Eliassen
Journal:  Breast Cancer Res Treat       Date:  2013-06-13       Impact factor: 4.872

8.  Hydroalcoholic extract of flaxseed improves polycystic ovary syndrome in a rat model.

Authors:  Gholamali Jelodar; Sajjad Masoomi; Farhad Rahmanifar
Journal:  Iran J Basic Med Sci       Date:  2018-06       Impact factor: 2.699

9.  Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer.

Authors:  Wendy Demark-Wahnefried; Stephen L George; Boyd R Switzer; Denise C Snyder; John F Madden; Thomas J Polascik; Mack T Ruffin; Robin T Vollmer
Journal:  Clin Trials       Date:  2008       Impact factor: 2.486

10.  Plant-Based Diet Index and Metabolic Risk in Men: Exploring the Role of the Gut Microbiome.

Authors:  Yanping Li; Dong D Wang; Ambika Satija; Kerry L Ivey; Jun Li; Jeremy E Wilkinson; Ruifeng Li; Megu Baden; Andrew T Chan; Curtis Huttenhower; Eric B Rimm; Frank B Hu; Qi Sun
Journal:  J Nutr       Date:  2021-09-04       Impact factor: 4.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.